Haleos Labs Ltd
SMSLIFE
Company Profile
Business description
Haleos Labs Ltd is engaged in the Business of manufacturing Active Pharmaceutical Ingredients (APIs) and its intermediates and sells its products in India as well as exports. The group sells its products in India and also exports it to other countries. Some of its API products are used in therapy as an Antiulcer, Antifungal, Anti Obesity, Anesthesia, and others. The company has manufacturing facilities at Kazipally and Jeedimetla and its Research and Development center at Sanatnagar in Hyderabad.
Contact
Road Number 71
Plot Number 19 - III
Opposite Bharatiya Vidya Bhavan Public School
Jubilee Hills
HyderabadTG500096
INDT: +91 4066288888
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2026
Employees
592
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks
Bapcor is paying for the sins of its past
Shares plunged over 17% after reporting disappointing results.
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,390.10 | 16.40 | 0.17% |
| CAC 40 | 8,225.73 | 19.66 | 0.24% |
| DAX 40 | 24,264.29 | 5.49 | 0.02% |
| Dow JONES (US) | 46,830.55 | 123.97 | 0.27% |
| FTSE 100 | 9,407.22 | 3.65 | 0.04% |
| HKSE | 26,027.55 | 168.72 | 0.65% |
| NASDAQ | 22,939.73 | 50.81 | -0.22% |
| Nikkei 225 | 49,316.06 | 130.56 | 0.27% |
| NZX 50 Index | 13,377.85 | 32.89 | 0.25% |
| S&P 500 | 6,732.13 | 3.00 | -0.04% |
| S&P/ASX 200 | 9,094.70 | 18.80 | 0.21% |
| SSE Composite Index | 3,916.33 | 52.44 | 1.36% |